Cita APA (7a ed.)
EER, H., W, H., EA, L., KA, C., MD, F., A, D., . . . LJ, S. (2006). The impact of HEr-2 status on loval recurrence in women with stage I-II breast cancer treated with breast-conserving therapy. Breast Journal, 12(5), 431-437.
Cita Chicago Style (17a ed.)
EER, Harris, Hwang W, Lee EA, Cengel KA, Feldman MD, DeMichele A, Kao G, y Solin LJ. "The Impact of HEr-2 Status on Loval Recurrence in Women with Stage I-II Breast Cancer Treated with Breast-conserving Therapy." Breast Journal 12, no. 5 (2006): 431-437.
Cita MLA (9a ed.)
EER, Harris, et al. "The Impact of HEr-2 Status on Loval Recurrence in Women with Stage I-II Breast Cancer Treated with Breast-conserving Therapy." Breast Journal, vol. 12, no. 5, 2006, pp. 431-437.
Precaución: Estas citas no son 100% exactas.